Nearly all Parkinson’s disease patients experience non-movement symptoms, such as sleep disturbances or depression, which affect their quality of life…
Articles by Patricia Inácio, PhD
Theranexus announced it is starting a Phase 2 clinical trial investigating THN102 as a potential therapy for Parkinson’s patients who…
Gocovri (amantadine) extended release oral capsules provided long-term improvements of motor complications in Parkinson’s disease patients, according to results from…
A new brain scanner, which is 10 times less expensive and much smaller than current models, has the potential to…
The mechanisms that lead to progressive degenerative diseases like Parkinson’s in adulthood begin much earlier than previously thought, a mouse study…
Computers may be taught to identify features in nerve cells that have not been stained or undergone other damaging treatments for…
Human neural stem cells show promise as therapy for Parkinson’s disease, according to six-month interim results of Phase 1 trial.
A startup developing a device for more affordable and efficient magnetic resonance imaging (MRI) scans was recently awarded a Small Business…
Clinical trials in patients with early stage Parkinson’s may benefit from assessing markers of disease progression — namely, changes in…
A new brain scanner that can be worn as a helmet could potentially revolutionize the world of human brain imaging,…